MIRSRT

N/A

Report date: 2025/04/17 10:26:16

Base Information

Drug NameMIRSRT
Drug Alias NameMIRSRT
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetic peripheral neuropathic pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJilin Tianheng Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJilin Tianheng Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetic peripheral neuropathic pain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A